Solid form Dhabi etexilate mesylate and methods for their preparation

摘要

The present invention relates to dabigatran etexylate mesylate in solid form, in particular dabigatran etexilate mesylate in crystalline form A and amorphous form, methods for their preparation, and pharmaceutical compositions containing them. It also relates to a crystalline form of dabigatran etexilate base (Form A) and a method for its preparation.